APA (7th ed.) Citation

Capdevila, J., Clive, S., Casado, E., Michie, C., Piera, A., Sicart, E., . . . Tabernero, J. (2013). A phase I pharmacokinetic study of PM00104 (Zalypsis((R))) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors. Cancer Chemotherapy & Pharmacology, 71(5), 1247. https://doi.org/10.1007/s00280-013-2119-8

Chicago Style (17th ed.) Citation

Capdevila, J., et al. "A Phase I Pharmacokinetic Study of PM00104 (Zalypsis((R))) Administered as a 24-h Intravenous Infusion Every 3 Weeks in Patients with Advanced Solid Tumors." Cancer Chemotherapy & Pharmacology 71, no. 5 (2013): 1247. https://doi.org/10.1007/s00280-013-2119-8.

MLA (9th ed.) Citation

Capdevila, J., et al. "A Phase I Pharmacokinetic Study of PM00104 (Zalypsis((R))) Administered as a 24-h Intravenous Infusion Every 3 Weeks in Patients with Advanced Solid Tumors." Cancer Chemotherapy & Pharmacology, vol. 71, no. 5, 2013, p. 1247, https://doi.org/10.1007/s00280-013-2119-8.